Researchers at the University of Geneva and ETH Zurich have achieved a significant breakthrough in noninvasive deep brain stimulation by introducing a third electrode pair to enhance precision. The innovation addresses a longstanding challenge in treating neurological and psychiatric disorders: delivering targeted brain stimulation without surgical implantation risks.
Using mouse models, the research team demonstrated that the enhanced three-electrode configuration substantially improves spatial accuracy compared to conventional two-electrode approaches. By better focusing stimulation on specific neural circuits while minimizing unintended activation of adjacent brain regions, this technique could expand treatment accessibility for conditions including Parkinson’s disease, depression, and other neurological conditions.
The findings represent a meaningful step toward bridging the gap between invasive surgical procedures and noninvasive therapeutic alternatives, potentially offering patients safer, more effective treatment options.
Read the full article on GMJ Newsroom.
Was this article helpful?
